Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content
Fig. 2 | BMC Immunology

Fig. 2

From: Bacille Calmette-Guérin-specific IgG titres among infants born to mothers with active tuberculosis disease in Uganda

Fig. 2

(A and B). Stored plasma was used to perform ELISA using the Human Tetanus Toxoid Antibody IgG (TT-IgG) ELISA Kit. The number of cases versus controls used at each visit was V0 = 18/17, V1 = 15/11, V2 = 11/10, and V3 = 9/4, respectivelyFig. e 2 (C and D). plasma was then used to perform ELISA using the Corynebacterium diphtheriae toxin IgG ELISA kit. The number of cases versus controls at V0 = 20/14, V1 = 15/15, V2 = 13/7, and V3 = 8/4, respectivelyFig. e 2 (E and F). Plasma was used to perform ELISA using the Human Measles virus IgG antibody (MV-Ab-IgG) ELISA Kit. The number of cases versus controls used at V0 = 20/16, V1 = 18/12, V2 = 11/9, and V3 = 8/5, respectively. Statistical differences were determined using mixed effects analysis and Tukey’s multiple comparison tests. Statistical significance was determined at p < 0.05 and a 95% confidence level. * and **** imply a p-value less than 0.05 and 0.0001, respectively. ** indicate a p-value less than 0.01

Back to article page

BMC Immunology

ISSN: 1471-2172

Contact us